Colorectal stenting was used in Queensland in several diverse scenarios, in both localized and metastatic disease. Surgery had a survival advantage, even in patients with metastatic disease. There was no survival difference according to whether patients were socioeconomically disadvantaged, diagnosed in a major city or not, or treated at private or public hospitals. Stenting proved a valid treatment option with low stoma rates.
Keyphrases
- healthcare
- antiplatelet therapy
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- minimally invasive
- squamous cell carcinoma
- small cell lung cancer
- climate change
- peritoneal dialysis
- free survival
- mental health
- health insurance
- acute coronary syndrome
- patient reported outcomes
- coronary artery disease
- surgical site infection